16Nov 2023
Impact of Empagliflozin on Left Ventricular Mass Regression in Asian Individuals with T2DM and CAD

Impact of Empagliflozin on Left Ventricular Mass Regression in Asian Individuals with T2DM and CAD

The study investigated whether the benefits of empagliflozin on left ventricular mass (LVM) regression varied among South Asian and non-South Asian individuals with type 2 diabetes and coronary artery disease. Despite baseline differences, the study found no substantial disparity in LVM regression between the two groups over the 6-month trial period. The study suggests that empagliflozin's impact on LVM is consistent across ethnicities in individuals with type 2 diabetes and coronary artery disease.

  • #cardiology

Like

Save

Share